Author

S. Villeneuve

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

A. Abdulkadir· 1 shared A. Boquet-Pujadas· 1 shared A. J. Saykin· 1 shared A. Singh· 1 shared A. Sotiras· 1 shared A. W. Toga· 1 shared B. Boyle· 1 shared B. H. Nelson· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. Abdulkadir

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pharmacological control of CAR T cells through CRISPR-driven rapamycin resistance

S. Levesque, G. Carleton, V. Duque, C. Goupil, J.-P. Fiset, S. Villeneuve, E. Normandeau, G. Morin, N. Dumont, B. H. Nelson, J. Laganiere, B. Boyle, J. J. Lum, Y. Doyon

This study develops a CRISPR-based method to create rapamycin-resistant CAR-T cells, enabling pharmacological control of their activity in cancer therapy.

bioRxiv · Sep 14, 2023 · PreprintCancer Biology

Genetic, Clinical Underpinnings of Brain Change Along Two Neuroanatomical Dimensions of Clinically-defined Alzheimer's Disease

J. Wen, Z. Yang, I. Nasrallah, Y. Cui, G. Erus, D. Srinivasan, A. Abdulkadir, E. Mamourian, I. Skampardoni, G. Hwang, A. Singh, M. Bergman, J. Bao, E. Varol, Z. Zhou, , Sh

This study identifies two brain atrophy dimensions in Alzheimer's disease using Surreal-GAN and links them to genetic and clinical factors, revealing distinct pathological mechanisms.

bioRxiv · Sep 16, 2022 · PreprintBioengineering